Education
About Us
Working with TipRanks
Follow Us
Rein Therapeutics (RNTX)
NASDAQ:RNTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -65.11M | $ -16.28K | $ -27.65K | $ -26.61K | $ -20.50K |
| EBITDA | $ -28.05M | $ -15.23K | $ -27.48K | $ -26.48K | $ -20.33K |
| Net Income | $ -62.88M | $ -15.73K | $ -27.33K | $ -26.16K | $ -21.16K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.87M | $ 17.31M | $ 21.24M | $ 45.93M | $ 13.80M |
| Total Assets | $ 69.24M | $ 106.01M | $ 22.01M | $ 48.48M | $ 16.34M |
| Total Debt | $ 0.00 | $ 48.00K | $ 33.00K | $ 162.00K | $ 387.00K |
| Net Debt | $ -12.87M | $ -17.27M | $ -5.16M | $ -3.44M | $ -6.66M |
| Total Liabilities | $ 14.85M | $ 99.12M | $ 3.38M | $ 4.58M | $ 4.18M |
| Stockholders' Equity | $ 54.39M | $ 6.89M | $ 18.62M | $ 43.90M | $ 12.16M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.29M | $ -19.81M | $ -24.86M | $ -23.91M | $ -20.48M |
| Operating Cash Flow | $ -22.29M | $ -19.81M | $ -24.86M | $ -23.75M | $ -20.48M |
| Investing Cash Flow | $ 0.00 | $ 16.20M | $ 26.46M | $ -35.92M | $ 6.41M |
| Financing Cash Flow | $ 17.82M | $ 15.79M | $ 0.00 | $ 55.66M | $ 15.80M |